1. Clinical exome sequencing: results from 2819 samples reflecting 1000 families.
- Author
-
Trujillano D, Bertoli-Avella AM, Kumar Kandaswamy K, Weiss ME, Köster J, Marais A, Paknia O, Schröder R, Garcia-Aznar JM, Werber M, Brandau O, Calvo Del Castillo M, Baldi C, Wessel K, Kishore S, Nahavandi N, Eyaid W, Al Rifai MT, Al-Rumayyan A, Al-Twaijri W, Alothaim A, Alhashem A, Al-Sannaa N, Al-Balwi M, Alfadhel M, Rolfs A, and Abou Jamra R
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Female, Flavoproteins genetics, Genetic Testing standards, Genotyping Techniques standards, Humans, Infant, Infant, Newborn, Intracellular Signaling Peptides and Proteins genetics, Male, Middle Aged, Mitochondrial Proteins genetics, NAV1.3 Voltage-Gated Sodium Channel genetics, Nuclear Family, Phenotype, Potassium Channels genetics, Protein Tyrosine Phosphatases, Non-Receptor genetics, Protoporphyrinogen Oxidase genetics, Sequence Analysis, DNA standards, Sodium Channels genetics, Voltage-Gated Sodium Channel beta-1 Subunit genetics, Exome, Genetic Testing methods, Genotyping Techniques methods, Sequence Analysis, DNA methods
- Abstract
We report our results of 1000 diagnostic WES cases based on 2819 sequenced samples from 54 countries with a wide phenotypic spectrum. Clinical information given by the requesting physicians was translated to HPO terms. WES processes were performed according to standardized settings. We identified the underlying pathogenic or likely pathogenic variants in 307 families (30.7%). In further 253 families (25.3%) a variant of unknown significance, possibly explaining the clinical symptoms of the index patient was identified. WES enabled timely diagnosing of genetic diseases, validation of causality of specific genetic disorders of PTPN23, KCTD3, SCN3A, PPOX, FRMPD4, and SCN1B, and setting dual diagnoses by detecting two causative variants in distinct genes in the same patient. We observed a better diagnostic yield in consanguineous families, in severe and in syndromic phenotypes. Our results suggest that WES has a better yield in patients that present with several symptoms, rather than an isolated abnormality. We also validate the clinical benefit of WES as an effective diagnostic tool, particularly in nonspecific or heterogeneous phenotypes. We recommend WES as a first-line diagnostic in all cases without a clear differential diagnosis, to facilitate personal medical care., Competing Interests: DT, AMBA, MERW, JK, KKK, AM, OP, MCdC, CB, KW, RS, JMGA, OB, SK, NN, MW, RAJ are employed at Centogene AG; AR has financial holdings in Centogene AG; WE, MTAR, AAR, WAT, AAlo, MAB, and MA are employees at King Abdulaziz Medical city; AAlh is employee at Prince Sultan Military Medical City; NAS is employee at Johns Hopkins Aramco hospital.
- Published
- 2017
- Full Text
- View/download PDF